2001
DOI: 10.1128/aem.67.11.5349-5349.2001
|View full text |Cite
|
Sign up to set email alerts
|

Development and Characterization of a Xylose-Dependent System for Expression of Cloned Genes in Bacillus subtilis : Conditional Complementation of a Teichoic Acid Mutant

Abstract: We have developed a xylose-dependent expression system for tight and modulated expression of cloned genes in Bacillus subtilis. The expression system is contained on plasmid pSWEET for integration at the amyE locus of B. subtilis and incorporates components of the well-characterized, divergently transcribed xylose utilization operon. The system contains the xylose repressor encoded by xylR, the promoter and 5 portion of xylA containing an optimized catabolite-responsive element, and intergenic xyl operator seq… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(26 citation statements)
references
References 23 publications
0
26
0
Order By: Relevance
“…Arabinose (1% w/v) was used as a carbon source in place of glucose. Xylose (1% w/v) was added to induce expression of Pxyl-rapI (Bhavsar et al, 2001). Antibiotics were used at the following concentrations for B. subtilis: kanamycin (5 μg ml −1 ), spectinomycin (100 μg ml −1 ), chloramphenicol (5 μg ml −1 ), tetracycline (10 μg ml −1 ), and a combination of erythromycin (0.5 μg ml −1 ) and lincomycin (12.5 μg ml −1 ) to select for macrolide-lincosamide-streptogramin (MLS) resistance.…”
Section: Media and Growth Conditionsmentioning
confidence: 99%
“…Arabinose (1% w/v) was used as a carbon source in place of glucose. Xylose (1% w/v) was added to induce expression of Pxyl-rapI (Bhavsar et al, 2001). Antibiotics were used at the following concentrations for B. subtilis: kanamycin (5 μg ml −1 ), spectinomycin (100 μg ml −1 ), chloramphenicol (5 μg ml −1 ), tetracycline (10 μg ml −1 ), and a combination of erythromycin (0.5 μg ml −1 ) and lincomycin (12.5 μg ml −1 ) to select for macrolide-lincosamide-streptogramin (MLS) resistance.…”
Section: Media and Growth Conditionsmentioning
confidence: 99%
“…We endeavored to complement the phosphate starvation growth phenotype in mutant strains by introducing a copy of glpQ or phoD at the amyE locus. To do this, we used a xyloseinducible promoter (33), but these attempts were frustrated by leakiness in the induction system that seemed to mask the effect of complementing genes during phosphate-limited growth. More compelling results were achieved with experiments that showed exogenous WTA stimulated phosphate-starved growth in complemented strains (supplemental Fig.…”
Section: Resultsmentioning
confidence: 99%
“…A strain containing an additional copy of yloQ at the amyE locus on the chromosome was created using the plasmid pSWEET as described previously [15]. Primers yloQ-F and yloQ-R were used to PCR-amplify the gene and clone into pSWEET.…”
Section: Deletion Of Yloqmentioning
confidence: 99%
“…We set out to characterize the biological function of YloQ with the construction of a B. subtilis strain that conditionally expressed yloQ. Using methods developed in our laboratory [15], a copy of yloQ was placed under the control of a tightly regulated xyloseinducible promoter at the amyE locus. Subsequently, the wildtype copy of yloQ was replaced with a spectinomycin resistance cassette.…”
Section: Creation Of a B Subtilis Yloq Deletion Strainmentioning
confidence: 99%